You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Bernstein Harold · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$254.5K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Sep 4, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 4 days later
MAZE daily price context
Close on/before transaction
$26.21
Sep 4, 2026
First close after public filing
$24.58
Sep 9, 2026
30-day return after filing
+5.29%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,705 shares @ $26.22
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050172-26-000036
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$254.5K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Sale | Sep 4, 2026 | $254.5K |